Applied Materials, Inc. (AMAT) Stock Price Today
Aura AI Summary
Key Stats
- $445.36BMarket Cap
- -Volume
- TechnologySector
- $723.0052W High
- $156.2552W Low
- -Typical Hold Time
- $444.38BEnterprise Value
- 0.38%Div Yield
- -Trading Activity
Track Applied Materials, Inc. (AMAT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Applied Materials, Inc. has traded between a low of $156.25 and a high of $723, highlighting its annual price range. Buy and sell Applied Materials, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Applied Materials, Inc.
Applied Materials is the world's largest supplier of semiconductor manufacturing equipment, providing materials engineering solutions to help make nearly every chip in the world. The firm's systems are used in nearly every major process step with the exception of lithography. Key tools include those for chemical and physical vapor deposition, etching, chemical mechanical polishing, wafer- and reticle-inspection, critical dimension measurement, and defect-inspection scanning electron microscopes.
Most Recent News
Jackery launches FridgeGuard, a smart fridge backup power, now exclusive at Costco.
Jackery has introduced FridgeGuard, the world's slimmest refrigerator backup power system, now available exclusively at Costco. Designed to protect refrigerators during power outages, it offers up to 15 hours of backup runtime, covering the average U...

Mass spectrometry market to double to $14.09B by 2035, driven by pharma and biotech growth
The global mass spectrometry market, valued at $6.68 billion in 2025, is projected to grow to $14.09 billion by 2035 at a CAGR of 7.74%. Growth is fueled by increased adoption in pharmaceutical manufacturing, biotechnology research, clinical diagnost...

Cancer biomarkers market to hit $54.48B by 2032, driven by tech advances and Asia-Pacific growth
The global cancer biomarkers market is projected to grow from $28.25 billion in 2026 to $54.48 billion by 2032, at an 11.6% CAGR. Growth is fueled by rising cancer rates, technological advances like multi-omics and AI integration, and increased deman...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.